Trials / Not Yet Recruiting
Not Yet RecruitingNCT06440486
Assessment of Probiotics on Inflammation and Metabolism in Type 2 Diabetes.
Based on a Randomized, Double-blind, Controlled Trial, Evaluate the Effects of Probiotics on Inflammation and Metabolism in Patients With Type 2 Diabetes Mellitus.
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study aims to explore the effects of probiotics on inflammatory and metabolic indicators in patients with type 2 diabetes. By assessing the potential of probiotics to modify these markers, the study seeks to identify an economical and effective strategy for the prevention and treatment of type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotics | Serum and fecal samples were collected at the beginning and end of the study to evaluate the effects of probiotic consumption on immune markers, metabolites, and gut microbiota before and after administration. |
Timeline
- Start date
- 2024-06-15
- Primary completion
- 2024-09-15
- Completion
- 2024-12-15
- First posted
- 2024-06-03
- Last updated
- 2024-06-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06440486. Inclusion in this directory is not an endorsement.